Scarica l'app Stockscreener
93.26
0.06%
-0.06
Dopo l'orario di chiusura:
93.12
-0.14
-0.15%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$93.32
Aprire:
$93.29
Volume 24 ore:
4.83M
Relative Volume:
0.60
Capitalizzazione di mercato:
$118.99B
Reddito:
$407.94B
Utile/perdita netta:
$2.90B
Rapporto P/E:
40.96
EPS:
2.2771
Flusso di cassa netto:
$7.39B
1 W Prestazione:
-2.74%
1M Prestazione:
+22.02%
6M Prestazione:
+19.52%
1 anno Prestazione:
+54.87%
Intervallo 1D:
$93.00
$94.15
Intervallo di 1 settimana:
$92.56
$96.45
Portata 52W:
$58.50
$98.43
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
93.26 | 119.07B | 407.94B | 2.90B | 7.39B | 2.2771 |
UNH
Unitedhealth Group Inc
|
388.47 | 347.35B | 449.71B | 12.81B | 19.67B | 13.24 |
ELV
Elevance Health Inc
|
394.69 | 84.65B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
286.24 | 74.60B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
307.95 | 36.46B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
Hospitals Sue CVS Health for $250M Pharmacy Scheme - planadviser
[Form 4] CVS HEALTH Corp Insider Trading Activity - Stock Titan
CVS (NYSE: CVS) files Form 144 for 32,000-share compensation sale - Stock Titan
CVS (CVS) files S-3 shelf registration to offer debt securities - Stock Titan
CVS Health Sued for Allegedly Withholding Funds From Hospitals - plansponsor
Bernstein Sees CVS Well Positioned for Medicare Advantage Turnaround - Insider Monkey
CVS Health Corp. stock (US1266501006): Glenview trims stake after 80% total return and strong Q1 mom - AD HOC NEWS
ABN Amro Investment Solutions Grows Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health (CVS) Experiences Strong Returns Amid Operational Tur - GuruFocus
CVS Health (NYSE: CVS) director-linked funds sell 3.75M shares and exit swaps - Stock Titan
Three major hospital systems accuse CVS of secretly siphoning hundreds of millions in drug savings - Fox Business
Glenview Capital sells 3.75M CVS shares, keeps it a top-3 holding - Stock Titan
[144] CVS HEALTH Corp SEC Filing - Stock Titan
CVS HealthYou're Not Alone: Why Maternal Mental Health Matters - ACCESS Newswire
CVS Health, Diocese of Camden, and The Walters Group Unite to Bring Senior Affordable Housing to Williamstown, New Jersey - PR Newswire
CVS Pharmacy's retail model and U.S. store network explained - AD HOC NEWS
MinuteClinic Highlights Access and Outcomes in Clinically Supervised Weight-Loss Program - ACCESS Newswire
ProShare Advisors LLC Purchases 19,018 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health stock (US1266501006): Stable Q1 growth keeps focus on margins and US healthcare demand - AD HOC NEWS
CVS Health Stock Rallies 24% in a Month as Business Turnback Fuels Rebound - NAI500
CVS Health stock (US1266501006): Mizuho lifts price target as shares hover in mid?$90s - AD HOC NEWS
Low digital health literacy hamstrings seniors' health IT use - TechTarget
CVS Maintained by Mizuho -- Price Target Raised to $110 - GuruFocus
Aetna Better Health(R) of Louisiana Collaborates With Goodr To Launch Mobile Food Market and Chronic Care Program - ACCESS Newswire
CVS Health pours $292M into veteran-run businesses and military families - Stock Titan
CVS Health Stock Is Soaring. Could the Rally Just Be Getting Started? - The Motley Fool
Mitsubishi UFJ Asset Management UK Ltd. Sells 12,000 Shares of CVS Health Corporation $CVS - MarketBeat
Resona Asset Management Co. Ltd. Sells 17,191 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Acquired by Northwestern Mutual Wealth Management Co. - MarketBeat
CVS Health stock (US1266501006): investors weigh Q1 earnings, new strategy and steady dividend - AD HOC NEWS
112,237 Shares in CVS Health Corporation $CVS Purchased by Fideuram Intesa Sanpaolo Private Banking S.P.A. - MarketBeat
Gamco Investors INC. ET AL Sells 14,768 Shares of CVS Health Corporation $CVS - MarketBeat
106,518 Shares in CVS Health Corporation $CVS Acquired by Atle Fund Management AB - MarketBeat
CVS Stock Price, Quote & Chart | CVS HEALTH CORP (NYSE:CVS) - ChartMill
CVS Health’s SWOT analysis: stock faces enrollment pressures amid margin recovery plan - Investing.com
University of Michigan Sues CVS Over 340B Drug Discount Profits - Bloomberg Law News
CVS chief snags $21.2M pay package with more than 90% tied to performance - The Business Journals
CVS Pharmacy spots shape how Americans fill prescriptions - AD HOC NEWS
CVS Health collaborates with America250 to support the nation’s 250th anniversary celebration - CVS Health
CVS Health® and WGU Launch Online Pre-Pharmacy Degree Program for Future Pharmacists Nationwide - marketscreener.com
CVS Health stock (US1266501006): Q1 earnings top estimates - AD HOC NEWS
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
CVS offloads Omnicare pharmacy unit in $250m bankruptcy sale - Insurance Business
CVS Health Corporation $CVS Stock Holdings Decreased by Gabelli Funds LLC - MarketBeat
iA Global Asset Management Inc. Invests $3.36 Million in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation (CVS) Announces Approval of 2026 Incentiv - GuruFocus
CVS Health stock (US1266501006): shares under pressure after guidance cut and restructuring push - AD HOC NEWS
CVS (CVS) investors back 2026 incentive plan and board, reject written-consent change - Stock Titan
Aetna Better Health of West Virginia opens resource center - Drug Store News
13 Companies Desperately Hiring Older Workers Right Now (Some Pay $30+ per Hour) - AOL.com
CVS Earnings Story Gains Fresh S&P 500 Attention - Kalkine Media
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cvs Health Corp Azioni (CVS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ROBBINS LARRY | Director |
May 19 '26 |
Sale |
94.45 |
1,983,538 |
187,341,308 |
6,213,261 |
| ROBBINS LARRY | Director |
May 20 '26 |
Sale |
93.82 |
1,018,000 |
95,510,822 |
5,195,261 |
| ROBBINS LARRY | Director |
May 21 '26 |
Sale |
93.45 |
370,462 |
34,619,007 |
4,824,799 |
1.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):